WVE
USDWave Life Sciences Ltd. Ordinary Shares
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$8.010
High
$8.270
Low
$7.950
Volume
1.95M
Company Fundamentals
Market Cap
1.3B
Industry
Biotechnology
Country
Singapore
Trading Stats
Avg Volume
2.52M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving muscle mass with once or
Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025
CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
This press release corrects and replaces the company's press release issued today, 10/29, at 4:15 p.m. ET in order to correct a typographical error in the first sub-bullet under "WVE-007 (GalNAc-siRNA)" – "Next steps."
Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is generally safe and well
Clear Street Initiates Coverage On WAVE Life Sciences with Buy Rating, Announces Price Target of $22
Clear Street analyst Bill Maughan initiates coverage on WAVE Life Sciences with a Buy rating and announces Price Target of $22.
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.